Members Members Residents Job Board
Join Today Renew Your Membership Make A Donation
2009 Program and Abstracts: A Systematic Review On the Surgical Treatment of Rectovaginal Fistulas in Crohn’S Disease: Rectal Vs Vaginal Advancement Flap
Back to Program | 2009 Program and Abstracts Overview | 2009 Posters
A Systematic Review On the Surgical Treatment of Rectovaginal Fistulas in Crohn’S Disease: Rectal Vs Vaginal Advancement Flap
Cesare Ruffolo1,2, Marco Scarpa3, Imerio Angriman*2
1IV Unit of Surgery, Regional Hospital Cà Foncello, Treviso, Treviso, Italy; 2Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy; 3Department of Surgery, Veneto Oncological Institute (IOV-IRCCS), Padova, Italy

Purpose Despite advances in the treatment of Crohn’s disease, the treatment of rectovaginal fistulas remains challenging. Rectal (RAF) and vaginal advancement flaps (VAF) represent two possible alternative surgical approaches to this problem. The study aims to review results of these surgical procedures for rectovaginal fistulas in Crohn’s disease.Methods: Medical databases from 1975 till August 2008 were consulted for potentially relevant publications. All studies dealing with the rectovaginal fistula repair in CD with rectal or vaginal advancement flaps were included. Two researchers worked independently on the study selection, quality assessment, data extraction and analysis phases of the study. Analyses were performed with Review Manager 2.0 softwareResults Eleven observational studies were included with a total of 219 flap procedures for RV fistula:. Primary fistula closure pooled rate was 54.2% (range 33.3-100%) after RAF and 69.4% (range 0-92.9%) after VAF (p=0.13). Four studies were eligible for proper metanalysis. In 56 patients the relative risk of primary fistula closure of RAF compared to VAF was 1.04(95% CI: 0.63-1.72). After 79 procedures the relative risk of overall success of RAF compared to VAF was 0.92 (95% CI: 0.58-1.45) (Figure 1). The relative risk of recurrence after RAF compared to VAF was 0.47 (95% CI: 0.15-1.46)(Figure 2); in this case only two studies were taken into consideration.Conclusions Although limited by a few number of studies of low clinical evidence level, this systematic review suggests that there is no significant difference in terms of outcome between RAF and VAF for rectovaginal fistulas in Crohn’s disease. Recurrence rates seem to be lower after RAF but only two studies were available for metanalysis.




Back to Program | 2009 Program and Abstracts | 2009 Posters


Society for Surgery of the Alimentary Tract

Facebook Twitter YouTube

Email SSAT Email SSAT
500 Cummings Center, Suite 4400, Beverly, MA 01915 500 Cummings Center
Suite 4400
Beverly, MA 01915
+1 978-927-8330 +1 978-927-8330
+1 978-524-0498 +1 978-524-0498
Links
About
Membership
Publications
Newsletters
Annual Meeting
Join SSAT
Job Board
Make a Pledge
Event Calendar
Awards